Eric Wee
Podiatrist · West Hills, CANPI 1710037197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $336 and has fallen 65.0% since, to $118 in 2022.
Across 43 payments — averaging $22.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$201
- Amgen$100
- Bayer$84
- Nestle Healthcare Nutrition Inc.$76
- Fidia Pharma USA Inc.$71
- Arbor Pharmaceuticals, Inc.$62
- plus $376 from 12 others
What the payments were for
- Food & beverage$970100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 6 | $201 |
| Amgen | 3 | $100 |
| Bayer | 4 | $84 |
| Nestle Healthcare Nutrition Inc. | 3 | $76 |
| Fidia Pharma USA Inc. | 5 | $71 |
| Arbor Pharmaceuticals, Inc. | 3 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Eisai Inc. | 3 | $51 |
| Hikma Pharmaceuticals USA | 3 | $51 |
| Amarin Pharma, Inc. | 2 | $41 |
| OPKO Pharmaceuticals, LLC | 1 | $26 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $25 |
| Vifor Pharma, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| AbbVie | 1 | $21 |
| Sanofi | 1 | $19 |
| Novo Nordisk | 1 | $18 |
How this compares
$970 in reported general payments places this provider in the 55th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 56 | $1,264 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in West Hills
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.